Mark Cavendish's Tour de France preparation disrupted with glandular fever diagnosis

Dimension Data sprinter expected to miss the Tour de Romandie and the Tour of California, disrupting his programme ahead of the Tour de France

Mark Cavendish in 2017 Milan-San Remo.

(Image credit: Yuzuru Sunada)

Mark Cavendish has been diagnosed with infectious mononucleosis - better known as glandular fever - caused by the Epstein-Barr virus, with his Dimension Data team unwilling to put a date on his return.

The Manx sprinter had already been suffering from an ankle injury that ruled him out of Paris-Roubaix, but will now require a longer period of rest than initially anticipated.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Henry Robertshaw began his time at Cycling Weekly working with the tech team, writing reviews, buying guides and appearing in videos advising on how to dress for the seasons. He later moved over to the news team, where his work focused on the professional peloton as well as legislation and provision for cycling. He's since moved his career in a new direction, with a role at the Department for Environment, Food and Rural Affairs.